Bitancor, Alexander C.

HRN: 22-11-62  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/25/2022
11/13/2022
IV
4.5g
Q6
Penunonia; Sepsis
Waiting Final Action 
10/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/26/2022
11/02/2022
IV
600mg
Q6hrs
T/C Aspiration Pneumonia
Waiting Final Action 
10/29/2022
MUPIROCIN 2%, 15G (TUBE)
10/29/2022
11/04/2022
TOPICAL
BID
BID
Decubitus Ulcer
Waiting Final Action 
10/31/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2022
11/03/2022
IV
4.5g
Q6
Pneumonia, Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: